Clinical Trial Update: A Comparison of Dalteparin and Tinzaparin for Prevention of Blood Clots in Hemodialysis Patients on Oral Anticoagulants Having Surgery [Phase 2, Phase 3]

View source ↗

Summary

Completed Phase 2/3 trial comparing dalteparin and tinzaparin for prevention of venous thromboembolism in hemodialysis patients undergoing surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Venous Thromboembolism

Drugs mentioned

• FRAGMIN (DALTEPARIN SODIUM)
• Innohep (tinzaparin)

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Thromboembolism, Hemodialysis | Phase 2, Phase 3 | Status: COMPLETED